ARCHIVES

Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 9 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

Health Disparities Between Minorities Too Large, Shalala Says

March 27, 1998

Also in this 12-page issue: NCI gives Doroshow and Fine “lead role” in clinical trials system review.

November 14, 2003

DCCPT Board, NCAB Approve Core Grant Guideline Changes, Consortium Centers

May 17, 1985

CCIRC Report Suggests Ways To Enhance Role Of Surgeons

July 22, 1977

USC wins $3.5 million NCI grant.

April 23, 2004

Cancer research poised for a “platinum age” as a “golden age” ends, NCI director tells AACR annual meeting.

April 29, 2005